Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 2,401 - 2,420 results of 21,342 for search '(( significantly ((lower decrease) OR (nn decrease)) ) OR ( significant decrease decrease ))', query time: 0.72s Refine Results
  1. 2401
    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup>

    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup> by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2402
    The Human Disharmony Loop Clinical Presentation.

    The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2403
    Patient Demographics.

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2404
    Pain and Function Outcomes Following PM Tenotomy.

    Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2405
    Diagnostic Criteria for Human Disharmony Loop.

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2406
    Normal Anatomy vs. Disharmonic Pathoanatomy.

    Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2407
    Sample Pain Diagrams.

    Sample Pain Diagrams. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2408
    Patient Example.

    Patient Example. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2409
    S1 Data -

    S1 Data - by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2410
    Elasticity and return to scale.

    Elasticity and return to scale. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2411
    Descriptive characteristics of the sample.

    Descriptive characteristics of the sample. by Ronna Bañada (19233063)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 2412
    Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation.

    Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2413
    Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + .

    Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + . by Maria Lage Barca (4515385)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2414
    Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group.

    Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group. by Maria Lage Barca (4515385)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2415
    Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness.

    Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2416
    Primer sequences for RT-qPCR.

    Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2417
    siRNA sequences and negative controls sequences.

    siRNA sequences and negative controls sequences. by Wenlong Shen (9313937)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2418
    Antibodies used in the study.

    Antibodies used in the study. by Wenlong Shen (9313937)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2419
    Changes in the monthly contamination rate (per set) in blood culture (BC).

    Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2420
    Patient background and blood culture-related factors before and after revision of the blood culture collection protocol.

    Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: